Intelligent Bio Solutions Inc. (INBS)

Every figure this model derived for INBS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 125,731 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 3,992,312 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 7,097,236 AssetsCurrent 2026-06-30
current liabilities 4,928,924 LiabilitiesCurrent 2026-06-30
equity 5,510,835 StockholdersEquity 2026-06-30
interest expense 10,736 InterestExpenseNonoperating 2026-06-30
ocf -11,927,222 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 4,215,175 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 195,208 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up INBS on one particular measure came for.

RatioValue
cash operating margin-265.52
current ratio1.44
current ratio reported1.44
dilution pct179.46
fcf margin-285.94
growth cv1.66
interest cover-1169.07
operating margin-297.76
owner earnings margin-290.57
revenue growth38.09
revenue growth per share-50.59
roic-647.42
rule of 40-259.67
sbc pct revenue4.63

What to be careful about

What this model itself distrusts about INBS's figures. Written by the derivation as it ran, not added afterwards.